| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | ZVRA Zevra Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 233,333 | 0.00 | 283,333 |
| 31 Jan 25 | ZVRA Zevra Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 233,333 | 0.00 | 466,667 |
| 16 May 24 | COLL Collegium Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 7,693 | 0.00 | 49,365 |
| 31 Jan 24 | ZVRA Zevra Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 700,000 | 0.00 | 700,000 |
| 10 Oct 23 | ZVRA Zevra Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 200,000 |
| 10 Oct 23 | ZVRA Zevra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.75 | 600,000 | 2.85 mm | 600,000 |
